AMA will take steps to promote diversity, equity, inclusion within the medical society and its journals
JAMA Journals Editor-in-Chief Steps Down After Deputy’s Racism Comments
AMA investigating how podcast and tweet, which contained controversial statements, were developed, reviewed, and published
ASCO: Nivolumab, Relatlimab Combo Slows Advanced Melanoma
Median progression-free survival of 10.1 versus 4.6 months seen among those receiving combo versus nivolumab alone, respectively
Many Americans Confused About Sunscreens: Poll
AAD poll highlights common misconceptions about sunscreen application
SARS-CoV-2 Reinfection Risk Low Among Health Care Workers
Risk for reinfection was significantly reduced by 85 percent with the presence of antibodies
Risk for Autoimmunity Up With Concomitant Vitiligo, Psoriasis
Occurrence of psoriasis was reported before vitiligo in 62.2 percent of patients, especially those with colocalization of lesions
Brooks-LaSure Confirmed as CMS Head
Brooks-LaSure will be the first Black person to lead CMS
Upadacitinib Treats Moderate-to-Severe Atopic Dermatitis
Two replicate double-blind, randomized, placebo-controlled trials show short-term efficacy for upadacitinib in adolescents and adults
More Body Surface Area Clearance With Psoriasis Tied to Better Quality of Life
Findings consistent at both six and 12 months of treatment with systemic therapy
Internet-Delivered CBT Reduces Atopic Dermatitis Symptoms
Significant reductions also seen in itch intensity, perceived stress, sleep problems, and depression